New Alzheimer's Drug: Targets the Microbiome To Reduce Brain Inflammation

[Gemini]

Oligomannate, a mix of oligosaccharides derived from seaweed, adjusts the microbiome such that inflammation-causing amino acids from gut bacteria no longer irritate the brain.

Chinese regulators have approved the drug; Phase 3 trials planned for US and Europe in early 2020.

https://www.cnn.com/2019/11/03/health/china-alzheimers-drug-intl-hnk-scli/index.html

 

[anne_likes_red]

What exactly would "inflammation-causing amino acids" be I wonder?

 

[Gemini]

What exactly would "inflammation-causing amino acids" be I wonder?

@anne_likes_red I believe the answer may be here:

https://www.nature.com/articles/s41422-019-0216-x